Italia markets open in 6 hours 7 minutes
Dow Jones
33.618,88 -388,00 (-1,14%) Nasdaq
13.063,61 -207,71 (-1,57%) Nikkei 225
31.996,95 -318,10 (-0,98%) EUR/USD
1,0561 -0,0015 (-0,14%) Bitcoin EUR
24.834,63 -59,13 (-0,24%) CMC Crypto 200
561,78 -2,04 (-0,36%)
AMGN Oct 2023 270.000 call
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Al 03:57PM EDT. Mercato aperto.
| Chiusura precedente | 4,55 |
| Aperto | 3,95 |
| Denaro | 5,65 |
| Lettera | 5,80 |
| Prezzo d'esercizio | 270,00 |
| Scadenza | 2023-10-20 |
| Min-Max giorno | 3,95 - 6,00 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 1,7k |
GlobeNewswireAmgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn’s Disease
Collaboration Brings Together TScan’s Proprietary Target Discovery Platform and Amgen’s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan’s proprietary target discovery
© 2023 Yahoo. Tutti i diritti riservati.
